Infectious Diseases Pharmacotherapy Residency (PGY2)
Application Deadline: 5:00 p.m. CST January 11, 2016
About the Program
The PGY-2 Infectious Diseases Pharmacotherapy Residency with the University of Houston College of Pharmacy and Cardinal Health is a 12-month residency experience in the heart of the Texas Medical Center (TMC), the world's largest medical center with more than 50 separate healthcare institutions.
The primary practice sites will be CHI St. Luke's Health - Baylor St. Luke's Medical Center and Cardinal Health, with elective opportunities at several other TMC institutions. Through required and elective rotations, the residency program is designed to develop expertise and clinical competence in pharmacotherapeutic, technological, and stewardship aspects of infectious diseases in various practice settings.
The applicant must possess a Pharm.D. degree and PGY1 pharmacy practice residency or equivalent experience. Licensure in the state of Texas is required. Applicants must submit curriculum vitae, a letter of intent, an official copy of transcripts (either mailed with packet or directly from institution) and three letters of reference to the following address by 5:00 p.m. CST January 11, 2016:
Dhara N. Shah, Pharm.D., BCPS
Director, ID Residency Program
University of Houston College of Pharmacy
1441 Moursund Ave.
Houston, TX 77030
Note to applicants: The UHCOP/Cardinal Health PGY-2 Infectious Diseases Residency is not an ASHP-accredited residency. Program administrators intend to submit the program for accreditation consideration.
- Clinical rotations (infectious diseases consult) at Baylor St. Luke’s Medical Center (3-4 months)
- Antimicrobial stewardship rotations at Cardinal Health (4 months)
- Research (1 month)
Elective rotation options (including but not limited to):
- Ambulatory HIV
- Inpatient infectious diseases consult
Total duration: 3-4 months
Residency activities (including but not limited to):
- Oral presentations (e.g., journal clubs, case presentations, a seminar on a controversial infectious disease pharmacotherapy topic)
- A major research project
- An infectious diseases lecture to third-year pharmacy students
- Facilitation of Pharmacotherapy Skills Lab
- Houston Infectious Disease Network (HIDN)
- Preceptorship during clinical rotations
- Academic teaching certificate program
Institutional Roles in Residency
University of Houston College of Pharmacy
Founded in 1946, the University of Houston College of Pharmacy (UHCOP) combines the opportunities and experiences of the Texas Medical Center's world-class healthcare community with resources of the University of Houston to offer its students the best possible education in pharmacy. The College is accredited by the Accreditation Council for Pharmacy Education and holds membership in the American Association of Colleges of Pharmacy.
The College's Pharmacy Practice and Translational Research Department is home to several nationally and internationally recognized faculty members with clinical and/or research practice in the area of Infectious Diseases. A proud member of the Texas Medical Center (TMC) for more than 30 years, the College provides optimal opportunities for interaction with practitioners from several renowned TMC institutions.
The resident will be based out of UHCOP's TMC Campus, with space allotted for the resident's work functions and where most of the resident's teaching responsibilities will be conducted. As desired, the resident also will have the opportunity to work in the Anti-Infective Research Laboratories in the UHCOP TMC Campus building. With more than six infectious diseases faculty (including the residency director) based within the same facility, the resident will be provided with unique opportunities for attaining professional growth as a clinician and academician.
Cardinal Health Innovative Delivery Solutions
Cardinal Health is a global healthcare business company and provider of pharmacy management services to acute care hospitals. Currently, Cardinal manages over 200 acute care hospitals that range in size from six to 1,000 beds.
Cardinal Health's focus is on improving patient outcomes delivered through expertise in pharmacy leadership, clinical programs and formulary management, medication safety and operational excellence.
The resident’s four-month experience with Cardinal Health will be focused on the development, implementation, and support of antimicrobial stewardship programs at both the hospital site level as well as within healthcare systems. The resident will be involved in all activities that pertain to infectious diseases, including:
- Reviewing new anti-infectives and developing formulary position statements;
- Developing clinical support materials for acute-care hospitals (such as anti-infective stewardship and the treatment of multi-drug resistant organisms);
- Partnering with the Cardinal Health Data and Analytics team to analyze patterns of anti-infective use and resistance;
- Conducting onsite antibiotic streamlining workshops for pharmacy staff at community-based hospitals, providing the resident with exposure to the non-academic institutional setting; and
- Collaborating remotely with field-based specialists through monthly journal clubs, webinars, and conference calls.
The PGY-2 Infectious Diseases Pharmacotherapy Residency program coordinators at Cardinal Health include Clinical Directors of Infectious Dieases Oscar Guzman, Pharm.D., BCPS, and Kate Shea, Pharm.D., BCPS-AQ-ID. With more than 20 years of combined clinical experience in infectious diseases and antimicrobial stewardship program management, the clinical specialists will serve as close mentors and teachers for the resident. Alongside the infectious disease specialists, the resident will support field-based clinical and operational specialists by providing up-to-date clinical information, antimicrobial stewardship guidance, and comprehensive tools to improve clinical outcomes and efficiency.
Baylor St. Luke's Medical Center
Baylor St. Luke's Medical Center, a tertiary care teaching hospital of CHI St. Luke's Health, is as an integral part of the Texas Medical Center and serves both the greater Houston area and the global community. In partnership with the medical staff, Baylor St. Luke's is dedicated to excellence and compassion in caring for the whole person - mind, body, and spirit.
Baylor St. Luke's is home to the Texas Heart Institute, consistently ranked among the top 10 cardiology and heart surgery centers in the nation by U.S. News and World Report. The Baylor St. Luke's Department of Pharmacy provides all contemporary services with an emphasis on being a pharmacist-centered pharmacy in a patient-centered hospital.
The pharmacy infectious diseases (ID) team at Baylor St. Luke's Medical Center includes full-time clinical specialists Hannah Palmer Russo, Pharm.D., BCPS, and Kady Phe, Pharm.D., BCPS; and UHCOP faculty members Nicholas Beyda, Pharm.D., BCPS; Kevin Garey, Pharm.D., M.S., FASHP; Dhara Shah, Pharm.D., BCPS; Amelia Sofjan, Pharm.D., BCPS; and Vincent Tam, Pharm.D., BCPS-AQ (ID).
The resident will become a part of the pharmacy ID team and round with an ID consult team that provides patient care services to critically ill patients, solid organ transplant patients, patients with liver cirrhosis, and general ward patients. The pharmacy ID team also serves as the pharmacy component of the hospital's antimicrobial stewardship program (the Center for Antimicrobial Stewardship and Epidemiology, which was recognized as a 2010 ASHP Best Practices site). In addition, numerous infectious diseases clinical research studies are conducted by this group.